Cough Syrup & Respiratory Medicine Manufacturer in India

WHO-GMP certified respiratory medicine manufacturing — antitussive, expectorant, mucolytic, bronchodilator and combination cough syrups — in standard, sugar-free and paediatric formulations for domestic distribution, institutional supply and international export.

Key Highlights

WHO-GMP
Certified Facility
Antitussive · Mucolytic
· Bronchodilator
15+ Countries
Supplied
DCGI Approved
Formulations

Request A Product List

Download Capability Brochure

About Respiratory

Respiratory medicine manufacturing expertise at 9M India

9M India manufactures a comprehensive range of respiratory medicines from a WHO-GMP certified liquid manufacturing facility in Birkoni, Chhattisgarh. Our respiratory portfolio covers the complete cough and cold medicine range — antitussive syrups (Dextromethorphan), expectorant syrups (Guaifenesin), mucolytic syrups (Ambroxol, Carbocisteine), bronchodilator syrups (Terbutaline, Salbutamol) and combination cough preparations including triple-combination formulations — in standard, sugar-free and paediatric variants.

Cough and cold medicines represent the single highest-volume liquid oral pharmaceutical category in the Indian domestic market and hold strong demand in export markets across Africa and South-East Asia. Combination cough syrups — particularly Ambroxol + Guaifenesin + Levosalbutamol triple-combination — are among the most prescribed and most tendered liquid formulations in the market.

Our respiratory portfolio also includes oral solutions, suspensions and tablets for bronchodilator and respiratory anti-infective applications. Sugar-free respiratory formulations are manufactured for diabetic patients and specific export markets with religious dietary restrictions on sugar content.

Full cough syrup range — antitussive, expectorant, mucolytic, bronchodilator, combination
Sugar-free and paediatric formulations across all respiratory products
Triple-combination cough syrups — Ambroxol + Guaifenesin + Levosalbutamol
Dry syrup (reconstitutable) and ready-to-use liquid respiratory formulations
WHO-GMP certified liquid manufacturing with in-house QC testing

Enquire Now

Our Capabilities

Respiratory medicine manufacturing
capabilities at 9M India

01

Dextromethorphan HBr syrup — centrally-acting antitussive for dry cough management. Guaifenesin syrup — expectorant for productive cough. Both available in standard and sugar- free variants. Manufacturing uses closed-system stainless steel liquid manufacturing with controlled API dissolution, preservative addition, pH adjustment and volume make-up. Taste profiling and sugar-free sweetener system validation is conducted for paediatric and diabetic patient formulations.
02

Ambroxol HCl syrup (15mg/5mL and 30mg/5mL) — mucolytic for productive cough with mucus hypersecretion. Carbocisteine syrup — mucolytic for chronic respiratory conditions. Both available in standard and sugar-free formulations. Ambroxol is one of the most prescribed single-ingredient mucolytic molecules in India with strong domestic and export demand. Validated assay by HPLC, microbial limits and preservative efficacy testing on every batch.
03

Terbutaline syrup (1.5mg/5mL) — beta-2 agonist bronchodilator for asthma and bronchospasm. Salbutamol oral solution — bronchodilator for bronchospasm management particularly in paediatric settings. These bronchodilator liquid formulations are particularly demanded in paediatric institutional supply where metered-dose inhalers are not suitable for younger age groups. Paediatric concentrations with validated dose uniformity and dosing accuracy confirmed with calibrated oral syringes.
04

Ambroxol + Guaifenesin + Levosalbutamol triple-combination syrup — the most widely prescribed combination cough formulation in India, combining mucolytic, expectorant and bronchodilator activity. Available in standard and sugar-free formulations. Manufacturing requires validated content uniformity for all three active components simultaneously, compatible stability profiles for the combination across shelf life and appropriate taste-masking for the combined API profile. 9M India validates individual assay for all three components on every batch.
05

Chlorpheniramine suspension — antihistamine for allergic rhinitis and upper respiratory allergy. Salbutamol suspension — paediatric bronchodilator. Amoxicillin dry syrup — antibiotic for respiratory bacterial infections (LRTI, URTI). These respiratory formulations complete the full range demanded in institutional paediatric care, NHM supply and export health programmes. All dry syrup formulations manufactured in humidity-controlled environments with validated reconstitution and post-reconstitution stability.

Dosage Forms

Respiratory formulations across dosage forms

Syrups — Ready-to-use
- Standard
- Sugar-free
- Paediatric
- Ambroxol
- Dextromethorphan
- Guaifenesin
- Terbutaline
- Combination
Syrups — Dry Syrup (Reconstitutable)
- Antibiotic dry syrups for respiratory infections
- Amoxicillin dry syrup
- Azithromycin dry syrup
- Cefixime dry syrup
Suspensions
- Paediatric suspensions
- Ready-to-use
- Salbutamol suspension
- Chlorpheniramine suspension
Oral Solutions
- Bronchodilator solutions
- Antihistamine solutions
- Salbutamol oral solution
- Cetirizine oral solution
Tablets & Capsules
- Standard
- Film-coated
- Salbutamol tablet
- Terbutaline tablet
- Montelukast tablet
- Cetirizine tablet

Why Choose Us

Why choose 9M India for respiratory medicine manufacturing

The complete cough syrup range. One WHO-GMP manufacturer.

Antitussive, expectorant, mucolytic, bronchodilator, antihistamine and combination cough syrups — all manufactured at 9M India's WHO-GMP certified liquid facility. Single-source supply for the entire respiratory syrup formulary.
Triple-combination cough syrup. Three actives. One validated batch.

Ambroxol + Guaifenesin + Levosalbutamol — individual HPLC assay for all three components on every batch. Content uniformity validated for each active independently and as a combination. Sugar-free and standard variants both available.
Sugar-free across the full respiratory range.

Every major respiratory syrup formulation available in sugar-free variant — using approved sweeteners with validated taste-masking. Essential for diabetic patients, export markets with sugar restrictions and paediatric palatability requirements.

Our Respiratory Range

Key respiratory formulations manufactured at 9M India

01

Ambroxol Syrup | Respiratory | Ready-to-use · Sugar-free | Mucolytic
02

Dextromethorphan Syrup | Respiratory | Ready-to-use | Antitussive
03

Guaifenesin Syrup | Respiratory | Ready-to-use | Expectorant
04

Terbutaline Syrup | Respiratory | Ready-to-use | Bronchodilator
05

Salbutamol Oral Solution | Respiratory | Ready-to-use | Bronchodilator
06

Ambroxol+Guaifenesin+Levosalbutamol | Respiratory | Combination syrup | Triple combination
07

Carbocisteine Syrup | Respiratory | Ready-to-use · Sugar-free | Mucolytic
08

Chlorpheniramine Suspension | Respiratory / Allergy | Suspension | Antihistamine
09

Cetirizine Syrup | Allergy / Respiratory | Ready-to-use | Antihistamine
10

Montelukast Tablet | Respiratory | Film-coated tablet | Leukotriene antagonist
11

Salbutamol Tablet | Respiratory | Standard tablet | Bronchodilator
12

Amoxicillin Dry Syrup | Respiratory anti-infective | Reconstitutable | Penicillin antibiotic

We keep answer short

Frequently asked questions —
respiratory medicine manufacturing

01

The complete cough syrup range — antitussive (Dextromethorphan), expectorant (Guaifenesin), mucolytic (Ambroxol, Carbocisteine), bronchodilator (Terbutaline, Salbutamol) and combination (Ambroxol+Guaifenesin+Levosalbutamol) — in standard, sugar-free and paediatric formulations.
02

Yes — sugar-free variants are available across all major respiratory syrup formulations. Approved sweeteners with validated taste-masking for target patient populations.
03

Yes — Ambroxol + Guaifenesin + Levosalbutamol combination syrup with validated individual HPLC assay for all three components. Both standard and sugar-free variants.
04

Yes — DCGI-approved with documentation pre-prepared for tender bid submission. Respiratory syrups are among the most tendered liquid formulations in NHM and state supply programmes.
05

Yes — age-appropriate bronchodilator and mucolytic syrups with validated dose uniformity and paediatric-calibrated dosing devices. Taste-masking validated for paediatric palatability.